Latest return on equity
Chemomab Therapeutics Return on equity
Direct answer
Chemomab Therapeutics's return on equity is -82.17%.
The verified market snapshot reports -82.17%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Chemomab Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -82.17%
Explore related company data
View Chemomab Therapeutics's market capitalizationView Chemomab Therapeutics's price-to-book ratioView Chemomab Therapeutics's dividend yieldView Chemomab Therapeutics's 52-week price rangeView Chemomab Therapeutics's profit marginView all Chemomab Therapeutics key metricsReturn to Chemomab Therapeutics profile